Literature DB >> 27118372

Reduced motor neuron excitability is an important contributor to weakness in a rat model of sepsis.

Paul Nardelli1, Jacob A Vincent2, Randall Powers3, Tim C Cope1, Mark M Rich4.   

Abstract

The mechanisms by which sepsis triggers intensive care unit acquired weakness (ICUAW) remain unclear. We previously identified difficulty with motor unit recruitment in patients as a novel contributor to ICUAW. To study the mechanism underlying poor recruitment of motor units we used the rat cecal ligation and puncture model of sepsis. We identified striking dysfunction of alpha motor neurons during repetitive firing. Firing was more erratic, and often intermittent. Our data raised the possibility that reduced excitability of motor neurons was a significant contributor to weakness induced by sepsis. In this study we quantified the contribution of reduced motor neuron excitability and compared its magnitude to the contributions of myopathy, neuropathy and failure of neuromuscular transmission. We injected constant depolarizing current pulses (5s) into the soma of alpha motor neurons in the lumbosacral spinal cord of anesthetized rats to trigger repetitive firing. In response to constant depolarization, motor neurons in untreated control rats fired at steady and continuous firing rates and generated smooth and sustained tetanic motor unit force as expected. In contrast, following induction of sepsis, motor neurons were often unable to sustain firing throughout the 5s current injection such that force production was reduced. Even when firing, motor neurons from septic rats fired erratically and discontinuously, leading to irregular production of motor unit force. Both fast and slow type motor neurons had similar disruption of excitability. We followed rats after recovery from sepsis to determine the time course of resolution of the defect in motor neuron excitability. By one week, rats appeared to have recovered from sepsis as they had no piloerection and appeared to be in no distress. The defects in motor neuron repetitive firing were still striking at 2weeks and, although improved, were present at one month. We infer that rats suffered from weakness due to reduced motor neuron excitability for weeks after resolution of sepsis. To assess whether additional contributions from myopathy, neuropathy and defects in neuromuscular transmission contributed to the reduction in force generation, we measured whole-muscle force production in response to electrical stimulation of the muscle nerve. We found no abnormality in force generation that would suggest the presence of myopathy, neuropathy or defective neuromuscular transmission. These data suggest disruption of repetitive firing of motor neurons is an important contributor to weakness induced by sepsis in rats and raise the possibility that reduced motor neuron excitability contributes to disability that persists after resolution of sepsis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Critical illness; ICU acquired weakness; Motoneuron; Motor unit; Muscle; Myopathy; Nerve; Neuromuscular junction; Neuropathy; Sepsis

Mesh:

Year:  2016        PMID: 27118372      PMCID: PMC4912926          DOI: 10.1016/j.expneurol.2016.04.020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  33 in total

1.  Sodium channel inactivation in an animal model of acute quadriplegic myopathy.

Authors:  M M Rich; M J Pinter
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

2.  ECG changes during septic shock.

Authors:  Mark M Rich; Mike L McGarvey; James W Teener; Lawrence H Frame
Journal:  Cardiology       Date:  2002       Impact factor: 1.869

3.  Effects of chronic sepsis on the voltage-gated sodium channel in isolated rat muscle fibers.

Authors:  Benoit Rossignol; Gildas Gueret; Jean-Pierre Pennec; Julie Morel; Marie A Giroux-Metges; Hélène Talarmin; Charles C Arvieux
Journal:  Crit Care Med       Date:  2007-02       Impact factor: 7.598

4.  Loss of electrical excitability in an animal model of acute quadriplegic myopathy.

Authors:  M M Rich; M J Pinter; S D Kraner; R L Barchi
Journal:  Ann Neurol       Date:  1998-02       Impact factor: 10.422

5.  Nerve excitability changes in critical illness polyneuropathy.

Authors:  W J Z'Graggen; C S Y Lin; R S Howard; R J Beale; H Bostock
Journal:  Brain       Date:  2006-08-10       Impact factor: 13.501

6.  Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats.

Authors:  Kevin R Novak; Paul Nardelli; Tim C Cope; Gregory Filatov; Jonathan D Glass; Jaffar Khan; Mark M Rich
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

7.  Matching between motoneurone and muscle unit properties in rat medial gastrocnemius.

Authors:  R Bakels; D Kernell
Journal:  J Physiol       Date:  1993-04       Impact factor: 5.182

8.  Muscle is electrically inexcitable in acute quadriplegic myopathy.

Authors:  M M Rich; J W Teener; E C Raps; D L Schotland; S J Bird
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

9.  Skeletal muscle contractile properties and proinflammatory cytokine gene expression in human endotoxaemia.

Authors:  F J McNicol; J A Hoyland; R G Cooper; G L Carlson
Journal:  Br J Surg       Date:  2010-03       Impact factor: 6.939

10.  Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading.

Authors:  Monica Llano-Diez; Guillaume Renaud; Magnus Andersson; Humberto Gonzales Marrero; Nicola Cacciani; Henrik Engquist; Rebeca Corpeño; Konstantin Artemenko; Jonas Bergquist; Lars Larsson
Journal:  Crit Care       Date:  2012-10-26       Impact factor: 9.097

View more
  13 in total

1.  Reduced Neural Excitability and Activation Contribute to Clinically Meaningful Weakness in Older Adults.

Authors:  Leatha A Clark; Todd M Manini; Nathan P Wages; Janet E Simon; David W Russ; Brian C Clark
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-03-31       Impact factor: 6.053

2.  Neuregulin-1β modulates myogenesis in septic mouse serum-treated C2C12 myotubes in vitro through PPARγ/NF-κB signaling.

Authors:  Li Liu; Xueru Liu; Yiping Bai; Ni Tang; Jie Li; Yingying Zhang; Jiali Wu; Xiaobin Wang; Jicheng Wei
Journal:  Mol Biol Rep       Date:  2018-09-03       Impact factor: 2.316

3.  Increasing motor neuron excitability to treat weakness in sepsis.

Authors:  Paul Nardelli; Randall Powers; Tim C Cope; Mark M Rich
Journal:  Ann Neurol       Date:  2017-12-07       Impact factor: 10.422

4.  Treatment of myotonia congenita with retigabine in mice.

Authors:  Chris Dupont; Kirsten S Denman; Ahmed A Hawash; Andrew A Voss; Mark M Rich
Journal:  Exp Neurol       Date:  2019-02-07       Impact factor: 5.330

5.  Chronic defects in intraspinal mechanisms of spike encoding by spinal motoneurons following chemotherapy.

Authors:  Stephen N Housley; Paul Nardelli; Randal K Powers; Mark M Rich; Timothy C Cope
Journal:  Exp Neurol       Date:  2020-06-05       Impact factor: 5.330

6.  Sarcopenia and Neuroscience: Learning to Communicate.

Authors:  Brian C Clark; Richard G Carson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-09-13       Impact factor: 6.053

7.  Imbalanced Subthreshold Currents Following Sepsis and Chemotherapy: A Shared Mechanism Offering a New Therapeutic Target?

Authors:  Mark M Rich; Stephen N Housley; Paul Nardelli; Randall K Powers; Timothy C Cope
Journal:  Neuroscientist       Date:  2020-12-21       Impact factor: 7.235

8.  Electrophysiological investigations of peripheral nerves and muscles: a method for looking at cell dysfunction in the critically ill patients.

Authors:  Nicola Latronico; Oliver Friedrich
Journal:  Crit Care       Date:  2019-01-29       Impact factor: 9.097

Review 9.  Intensive Care Unit-Acquired Weakness: A Review of Recent Progress With a Look Toward the Future.

Authors:  Wenkang Wang; Chuanjie Xu; Xinglong Ma; Xiaoming Zhang; Peng Xie
Journal:  Front Med (Lausanne)       Date:  2020-11-23

10.  Neural circuit mechanisms of sensorimotor disability in cancer treatment.

Authors:  Stephen N Housley; Paul Nardelli; Travis M Rotterman; Timothy C Cope
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.